eCOA Resources

  1. Expanding Flexibility Of eCOA Data Collection With Controlled Interview Mode 1/31/2022

    Discover how the interview mode constitutes an additional data entry mode for ePROs when clinical trial participants cannot go to the study site for a scheduled visit.

  2. Embracing Accessibility: The Future Of Clinical Trials 10/16/2023

    Explore the reasons why accessibility stands as a crucial pillar for the prosperity of biopharmaceutical and clinical research, having evolved into an all-encompassing industry imperative.

  3. The Case For Cognitive Assessments In Phase 1 Clinical Trials 7/16/2024

    Regulators prioritize patient-reported outcomes. Cognitive assessments in Phase 1 trials detect early drug-related cognitive effects, ensuring safety and efficacy. Signant’s CDR System® is a proven tool for this.

  4. The Win-Win Wth Virtual Visits – Better Experiences, Better Data 2/29/2024

    Discover how researchers can design studies with the needs of the patient in mind to promote faster enrollment, high engagement, and the production of more complete and accurate data.

  5. C3 Summit Recap: Shaping The Future Of eCOA/ePRO Highlights 2/10/2022

    Understand how the rapid shift to decentralized clinical trials required pharma companies and CROs to adapt data capture techniques quickly while remaining compliant with local regulations.

  6. Common Challenges In Clinical Trials And How eCOA Can Solve Them 7/20/2022

    Choosing an eCOA provider can be daunting and time consuming, while adhering to the timelines and needs of your study. Learn how an eCOA solution, backed by a DCT platform, can be a benefit to your study.

  7. Our Unified Platform Serves As eSource For COVID Treatment Trial 6/17/2024

    Signant Biotech optimized technology for an emerging biopharmaceutical's Phase 2 COVID treatment trial in critically ill patients, minimizing paper data risks and streamlining consent and data management across multiple sites and solutions.

  8. Combining Patient-Centric Technology and RWD For Comprehensive Evidence 8/10/2022

    Explore how by combining digital technologies with secondary RWD, researchers can gather a more holistic understanding of the patient. 

  9. Modern Architecture's Impact On UX In Next-Gen Interactive Response Tech 8/21/2023

    Explore how Interactive Response Technologies (IRTs) built around microservices models can provide faster initial builds, more rapid change management, and improved built-in test automation.

  10. Optimizing Prader-Willi Syndrome Clinical Trials 10/21/2024

    Learn how Signant is helping to mitigate placebo responses and ensuring high-quality data to improve Prader-Willi syndrome (PWS) clinical trial success.